An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases
ENROLLING
Trial ID:
NCT04554914 Protocol # :
21-114
Phase
II
Disease Sites
Other Hematopoietic
Non-Hodgkin's Lymphoma
Hodgkin's Lymphoma
Multiple Myeloma
Lymphoid Leukemia
Myeloid and Monocytic Leukemia
Leukemia, other
Principal Investigator
Nikiforow, Sarah
Site Research Nurses
Beshere, Gianna
Fontana, Brittney
Halloran, Elizabeth
More, Avnee, P.
Pasquale, Kathryn, Mary
Verrill, Kelly
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-114
21-114